Introduction
============

Chronic diseases, frequently classified as a major component of non-communicable diseases, usually affect middle-aged or elderly individuals after prolonged exposure to an unhealthy lifestyle, which is often related to the economic transition, rapid urbanization, and 21st-century lifestyles, with behaviors such as tobacco use, harmful consumption of alcohol, an unhealthy fast food diet, insufficient physical activity, and extended working hours. Physiologically stressed lifestyles increase the prevalence of risk factors, such as hypertension, dyslipidemia, diabetes, respiratory diseases, and obesity, which act in parallel and synergistically on various metabolic pathways in the body \[[@b1-kjtcvs-50-086]\]. The chronic accumulation of these adverse effects can lead to lethal disease.

The World Health Organization suggested that around 56 million deaths occurred worldwide in the year 2012, of which 38 million (68%) were due to non-communicable diseases. If cancers are excluded, ischemic heart disease (IHD), stroke, chronic obstructive pulmonary disease (COPD), and diabetes are the chief causes of deaths \[[@b2-kjtcvs-50-086]\]. In the Republic of Korea, the prevalence of hypertension, diabetes, IHD, stroke, and COPD among people aged 65 years or older are 56.7%, 22.6%, 6.8%, 6.9%, and 30.2%, respectively \[[@b3-kjtcvs-50-086]\].

Lifestyle factors can cause various types of cancers. The emergence of the lung cancer epidemic in the 20th century was driven by smoking. Additionally, many other risk factors of lung cancer have been reported, including diet (cured meat or deep-fried cooking), alcohol, and insufficient exercise \[[@b4-kjtcvs-50-086]\]. In some countries, a decline in cigarette smoking rates resulting from strong public health policies has reduced the incidence of lung cancer, but lung cancer remains the leading cause of cancer-related mortality around the world. Numerous studies about the impact of comorbidities on the treatment of lung cancer have presented various validated scales to assess comorbidities, such as the Charlson Comorbidity Index (CCI). However, few studies have focused specifically on lifestyle diseases.

The frequency with which early-stage lung cancers are diagnosed has increased owing to advances in high-resolution computed tomography and the greater prevalence of computed tomographic screening \[[@b5-kjtcvs-50-086]\]. Therefore, we performed this study to evaluate the impact of lifestyle diseases on postoperative complications and long-term survival in elderly patients with pathologic stage I non-small cell lung cancer (NSCLC).

Methods
=======

The medical records of 110 patients who underwent curative resection for stage I NSCLC at a single institute between December 1995 and November 2013 were reviewed. All of them were 65 years or older, and underwent lobectomy or pneumonectomy with mediastinal lymph node dissection. We excluded patients with a history of other malignant disease, neoadjuvant treatment, sublobar resection, or uncommon histologic subtypes other than adenocarcinoma or squamous cell carcinoma. The pathologic stage of all tumors was assessed according to the seventh edition of the TNM (tumor-node-metastasis) classification of the International Union Against Cancer.

In all patients, the preoperative diagnostic workup included a medical history, physical examination, plain chest radiography, electrocardiography, routine laboratory tests, pulmonary function test, and computed tomography of the chest. If the tissue diagnosis was confirmed, additional staging procedures, such as a bone scan, brain magnetic resonance imaging, and positron emission tomography-computed tomography were performed.

Patients were followed with regular visits to the outpatient clinic or through telephone contact. Follow-up was completed in all patients through June 2015. The median follow-up time was 40.4 months (range, 0.4 to 222.3 months). Overall survival was measured from the date of surgery to the date of death or the last follow-up contact.

Postoperative complications were defined as any deviation from the normal postoperative course occurring in the initial 30 days after surgery. These complications included air leakage, atrial fibrillation, delirium, atelectasis, acute kidney injury (AKI), pneumonia, and acute respiratory distress syndrome (ARDS). Air leakage was defined as a leak that persisted for more than 7 days after surgery.

The relationships of the following variables with postoperative complications and overall survival were evaluated: age, sex, smoking, each individual lifestyle disease, the presence of a lifestyle disease, forced expiratory volume in 1 second, body mass index (BMI), surgical technique, operative time, tumor size, tumor site, extent of resection, pathologic stage, and histologic subtype. The following highly prevalent lifestyle-related and chronic diseases were analyzed: hypertension, diabetes, IHD, stroke, and COPD. The variable 'presence of a lifestyle disease' applied to patients with 1 or more of the above 5 lifestyle diseases.

Categorical data were analyzed using the chi-square test or the Fisher exact test. The Student t-test was used to analyze continuous variables. Survival curves were estimated by the Kaplan-Meier method, and compared using the log-rank test. Univariate and multivariate analyses for postoperative complications and survival were performed by means of a binary logistic regression model and a Cox proportional hazard model. Variables that had p-values \<0.2 or \<0.05 in the univariate analysis were selected for inclusion in the multivariate analysis of postoperative complications and overall survival, respectively. All statistical analyses were carried out in IBM SPSS Statistics ver. 20.0 (IBM Corp., Armonk, NY, USA). p-values \<0.05 were considered to indicate statistical significance.

Results
=======

Among 110 patients, there were 76 males and 34 females. Sixty-three patients (57.3%) had lifestyle diseases, and 36 patients (32.7%) were non-smokers. Their mean age was 70.7 years (range, 65 to 82 years). Adenocarcinoma (61.8%) was more frequent than squamous cell carcinoma (38.2%). Seventy-one patients (64.5%) had stage IA lung cancer, and 39 patients (35.5%) were diagnosed with stage IB disease. The following types of pulmonary resection were performed: lobectomy (87.3%) and bilobectomy or pneumonectomy (12.7%). Forty-five patients (40.9%) underwent video-assisted thoracoscopic surgery (VATS). Upper-lobe (including middle-lobe) tumors were more common (58.2%) than lower-lobe tumors (41.8%). Right-sided tumors occurred in 70 cases (63.6%), and left-sided tumors in 40 cases (36.4%). The median tumor size was 2.8 cm (range, 0.5 to 5.0 cm). Further details of the patients' baseline characteristics are shown in [Table 1](#t1-kjtcvs-50-086){ref-type="table"}.

Sixty-three patients (57.3%) had lifestyle diseases. The most common lifestyle disease was hypertension (n=46, 41.8%), and the second most frequent disease was diabetes (n=23, 20.9%), followed by IHD (13.6%), COPD (9.1%), and stroke (5.5%) ([Table 2](#t2-kjtcvs-50-086){ref-type="table"}).

The 30-day postoperative mortality rate was 0.9% (n=1). The cause of death was pneumonia. The number of postoperative cases of mortality was too low to identify any statistically significant associations. The details of the postoperative complications are shown in [Table 3](#t3-kjtcvs-50-086){ref-type="table"}. The most common complications were air leakage (6.4%) and atrial fibrillation (5.5%), followed by delirium (4.5%), atelectasis (4.5%), AKI (2.7%), pneumonia (2.7%), and ARDS (1.8%).

In the univariate and multivariate analyses of postoperative complications, no lifestyle disease showed any association with postoperative complications ([Table 4](#t4-kjtcvs-50-086){ref-type="table"}). Instead, the presence of a lifestyle disease was related with an increased incidence of postoperative complications (odds ratio, 2.49; 95% confidence interval \[CI\], 1.02 to 6.07; p=0.045). No other factors were found to be significantly related with postoperative complications.

The 3-year and 5-year overall survival rates were 78.3% and 63.6%, respectively. When evaluating risk factors for overall survival in the univariate analysis, age, smoking, BMI, resection type, and stage were significantly associated with impaired survival. In the multivariate analysis, the resection type (hazard ratio \[HR\], 2.20; 95% CI, 1.08 to 4.49; p=0.030) and pathologic stage (HR, 1.89; 95% CI, 1.02 to 3.49; p=0.043) were independent poor prognostic factors. All of the individual lifestyle diseases and the presence of a lifestyle disease were not factors that significantly affected overall survival ([Table 5](#t5-kjtcvs-50-086){ref-type="table"}). The Kaplan-Meier curves showed differences in the survival rate according to the resection type (p=0.001) and pathologic stage (p=0.014) ([Fig. 1A, B](#f1-kjtcvs-50-086){ref-type="fig"}). However, the overall survival curves according to the presence of a lifestyle disease showed no significant difference (p=0.338) ([Fig. 1C](#f1-kjtcvs-50-086){ref-type="fig"}).

Discussion
==========

Recent changes in lifestyle have increased the prevalence of lifestyle diseases. The prevalence of comorbidities, including lifestyle diseases, is higher in older patients than in younger patients, and the incidence of lung cancer is also higher in older populations \[[@b6-kjtcvs-50-086]\]. Various validated scales to assess comorbidities in patients with lung cancer include the CCI, the Cumulative Illness Rating Scale for Geriatrics, the Simplified Comorbidity Score, the Adult Comorbidity Evaluation, and the Older American Resources and Services Comorbidity Scale. However, these scales may not be specific to patients with cancer or may be cumbersome to use \[[@b7-kjtcvs-50-086]\]. No study has yet been carried out to e valuate the relationships between lifestyle diseases and postoperative complications or survival in patients with lung cancer. Therefore, we investigated the association between lifestyle diseases and postoperative outcomes in elderly patients with stage I NSCLC.

According to various recent studies on the comorbidities of lung cancer patients, hypertension, COPD, IHD, stroke, and diabetes are highly prevalent. These diseases are closely associated with lifestyle factors, and tend to progress to chronic conditions. Therefore, in the present study, these 5 diseases were defined as lifestyle diseases, and their frequencies were as follows: hypertension (41.8%), diabetes (20.9%), IHD (13.6%), COPD (9.1%), and stroke (5.5%).

Many studies have described the prognostic impacts of comorbidities on postoperative complications after NSCLC surgery. Pei et al. \[[@b8-kjtcvs-50-086]\] reported that each lifestyle disease influenced postoperative complications. Okami et al. \[[@b9-kjtcvs-50-086]\] studied the risk factors for complications after surgery in patients aged 80 years or older with clinical stage I NSCLC, and reported that the presence of comorbidities (excluding hypertension) was a factor associated with operative risks. On the contrary, Shiono et al. \[[@b10-kjtcvs-50-086]\] reported that the presence of comorbidities, including lifestyle diseases, did not affect postoperative complications in elderly patients. In the present study, postoperative complications were not associated with any specific lifestyle disease, but rather with the presence of a lifestyle disease. Postoperative complications have been argued to be closely associated with the postoperative systemic inflammatory response, but the correct mechanism has not yet been clearly identified \[[@b11-kjtcvs-50-086]\]. The frequency of postoperative complications is also thought to increase as the postoperative systemic inflammatory response worsens due to the operation in patients with a lifestyle disease, because these diseases are chronic inflammatory diseases. However, in this study, no statistically significant associations were observed between undergoing VATS and the incidence of postoperative complications, although VATS is generally accepted as a surgical technique that can reduce the postoperative inflammatory response. An analysis with a larger sample size may show a statistically significant association.

In summary, to prevent postoperative complications, optimization of the patient's preoperative condition regarding lifestyle diseases, the administration of preoperative medications to relieve inflammation, and minimally invasive surgery (VATS) can be considered. By doing this, the postoperative systemic inflammatory response will be reduced, and consequently, postoperative complications will also be decreased.

The effects of comorbid conditions, including lifestyle diseases, on survival have drawn significant research interest, although the results have been inconsistent. Some studies have shown comorbidities to be independent prognostic factors for lung cancer survival \[[@b12-kjtcvs-50-086],[@b13-kjtcvs-50-086]\]. Battafarano et al. \[[@b14-kjtcvs-50-086]\] investigated the impact of comorbidities on long-term survival after surgical resection in 451 patients with stage I NSCLC. They classified the severity of comorbidities using the modified Kaplan-Feinstein index, and confirmed that patients with moderate and severe comorbidities were approximately twice as likely to die as were patients with no comorbidities. Moro-Sibilot et al. \[[@b15-kjtcvs-50-086]\] showed a significant impact of comorbidities on survival after resection of 588 patients with pathologic stage I NSCLC. They showed that independent prognostic values were associated with stroke and the CCI. According to the report of Birim et al. \[[@b16-kjtcvs-50-086]\], in which comorbid conditions, the CCI, and survival were assessed in patients who underwent curative resections for NSCLC, the CCI was found to be a better prognostic factor than the individual comorbid conditions. Comorbidities potentially affect lung cancer survival in several ways. Certain conditions, including COPD, stroke, and IHD were found to have an independent negative effect on survival. In addition, comorbid conditions could camouflage cancer symptoms and cause a delay in the diagnosis. Additionally, the presence of comorbidities could prevent a complete diagnostic evaluation, leading to less accurate staging. Comorbidities also influence treatment selection, preventing patients from receiving aggressive lung cancer treatment \[[@b12-kjtcvs-50-086],[@b17-kjtcvs-50-086]\]. However, in this study, lifestyle diseases did not show a significant relationship with the survival of lung cancer patients. This result seems to arise from the features of lifestyle diseases and lung cancer. The deleterious effects of lifestyle diseases can diminish the function of vital organ systems slowly over time \[[@b12-kjtcvs-50-086]\]. In contrast, lung cancer is one of the most aggressive forms of cancers, with a generally poor prognosis. The overwhelming fatality of lung cancer might offset the effect of lifestyle diseases on survival.

The biases and limitations of this study are as follow s. First, patient selection bias may have been inevitable due to the fact that this was a single-institute retrospective study. Second, the relatively small number of cases included in the analysis could limit the accuracy of the results. Third, an assessment of comorbidity severity was not been included in this study. Considering such limitations and biases, the clinical application of the presence of a lifestyle disease as a predictive variable for postoperative complications, as proposed in this study, may be controversial.

In summary, we investigated the effect of lifestyle diseases on the morbidity and overall survival of lung cancer patients in 2 ways: (1) the morbidity rate and overall survival rate were compared in lung cancer patients with and without lifestyle diseases, and (2) the morbidity rate and overall survival rate of lung cancer patients with any 1 of the 5 lifestyle diseases were compared with the corresponding rates in patients with no lifestyle diseases. The 5 lifestyle diseases were hypertension, diabetes, IHD, stroke, and COPD. The results of this study showed that the presence of a lifestyle disease was a significant prognostic factor for postoperative complications, but not of survival rates in elderly stage I NSCLC patients. Therefore, postoperative complications may be influenced by the presence of a lifestyle disease.

This study was supported by a Grant of the Samsung Vein Clinic Network (Daejeon, Anyang, Cheongju, Cheonan; Fund No. KTCS04-067).

This article was presented at the 47th Annual Meeting of the Korean Society for Thoracic and Cardiovascular Surgery, Jeongseon, Korea, October 22--24, 2015.

**Conflict of interest**

No potential conflicts of interest relevant to this article are reported.

![(A) Overall survival curves according to the pathologic stage. (B) Overall survival curves according to the resection type. (C) Overall survival curves according to the presence of a lifestyle disease.](kjtcvs-50-086f1){#f1-kjtcvs-50-086}

###### 

Characteristics of the 110 patients with completely resected stage I non-small cell lung cancer

  Characteristic                          Value
  --------------------------------------- ----------------
  Sex                                     
   Male                                   76 (69.1)
   Female                                 34 (30.9)
  Age (yr)                                70.73±3.78
   65--69                                 47 (42.7)
   70--74                                 44 (40.0)
   ≥75                                    19 (17.3)
  Presence of a lifestyle disease         
   No                                     47 (42.7)
   Yes                                    63 (57.3)
  Smoking                                 
   Non                                    36 (32.7)
   Current/past                           74 (67.3)
  FEV~1~, (L)                             2.21±0.59
  FEV~1~ (%)                              95.0±18.8
  Body mass index (kg/m^2^)               23.2±2.9
  Surgical technique                      
   Thoracotomy                            65 (59.1)
   Video-assisted thoracoscopic surgery   45 (40.9)
  Operative time (min)                    239 (95--495)
  Tumor location                          
   Upper lobe (including middle lobe)     64 (58.2)
   Lower lobe                             46 (41.8)
  Tumor laterality                        
   Right-sided                            70 (63.6)
   Left-sided                             40 (36.4)
  Resection type                          
   Lobectomy                              96 (87.3)
   Bilobectomy/pneumonectomy              14 (12.7)
  Tumor size (cm)                         2.8 (0.5--5.0)
  Pathologic stage                        
   IA                                     71 (64.5)
   IB                                     39 (35.5)
  Histologic type                         
   Adenocarcinoma                         68 (61.8)
   Squamous cell carcinoma                42 (38.2)

Values are presented as number (%), mean±standard deviation, or mean (range).

FEV~1~, forced expiratory volume in the first second.

###### 

Details of lifestyle diseases

  Type of lifestyle disease               No. of patients (%)
  --------------------------------------- ---------------------
  Hypertension                            46 (41.8)
  Diabetes                                23 (20.9)
  Ischemic heart disease                  15 (13.6)
  Chronic obstructive pulmonary disease   10 (9.1)
  Stroke                                  6 (5.5)

###### 

Details of postoperative complications

  Type of complication                  No lifestyle disease (n=47)   Lifestyle disease (n=63)   No. of total patients (%)
  ------------------------------------- ----------------------------- -------------------------- ---------------------------
  Air leak                              4                             3                          7 (6.4)
  Atrial fibrillation                   \-                            6                          6 (5.5)
  Delirium                              1                             4                          5 (4.5)
  Atelectasis                           1                             4                          5 (4.5)
  Acute kidney injury                   1                             2                          3 (2.7)
  Pneumonia                             1                             2                          3 (2.7)
  Acute respiratory distress syndrome   1                             1                          2 (1.8)
  Asthma aggravation                    \-                            2                          2 (1.8)
  Wound infection                       1                             \-                         1 (0.9)
  Pulmonary edema                       \-                            1                          1 (0.9)
  No. of total patients (%)             9 (19.1)                      23 (36.5)                  32 (29.1)

Some patients had more than one complication.

###### 

Univariate and multivariate analysis of postoperative complications in 110 patients

  Variable                                       Postoperative complication (n=32)                          
  ---------------------------------------------- ----------------------------------- ---------------------- -------
  Sex                                            0.960                                                      
                                                                                                            
  Age                                            0.777                                                      
                                                                                                            
  Diabetes (yes)                                 0.721                                                      
                                                                                                            
  Hypertension (yes)                             0.265                                                      
                                                                                                            
  Chronic obstructive pulmonary disease (yes)    0.151                                                      0.356
                                                                                                            
  Stroke (yes)                                   0.670                                                      
                                                                                                            
  Ischemic heart disease (yes)                   0.130                                                      0.378
                                                                                                            
  Presence of a lifestyle disease                0.047                                                      
                                                                                                            
   No                                                                                Reference              
                                                                                                            
   Yes                                                                               2.490 (1.022--6.068)   0.045
                                                                                                            
  Smoking                                        0.832                                                      
                                                                                                            
  Forced expiratory volume in the first second   0.119                                                      0.210
                                                                                                            
  Body mass index                                0.617                                                      
                                                                                                            
  Surgical technique                             0.214                                                      
                                                                                                            
  Operation time                                 0.292                                                      
                                                                                                            
  Tumor location                                 0.062                                                      0.086
                                                                                                            
  Tumor laterality                               0.552                                                      
                                                                                                            
  Resection type                                 1.000                                                      
                                                                                                            
  Tumor size                                     0.929                                                      
                                                                                                            
  Pathologic stage                               0.880                                                      
                                                                                                            
  Histologic type                                0.338                                                      

Variables with a p-value of\<0.2 were entered into the multivariate analysis.

###### 

Univariate and multivariate analysis for overall survival in 109 patients

  Variable                                       Survival (n=109)                          
  ---------------------------------------------- ------------------ ---------------------- -------
  Sex                                            0.063                                     
                                                                                           
  Age                                            0.042                                     0.106
                                                                                           
  Diabetes (yes)                                 0.364                                     
                                                                                           
  Hypertension (yes)                             0.198                                     
                                                                                           
  Chronic obstructive pulmonary disease (yes)    0.630                                     
                                                                                           
  Stroke (yes)                                   0.842                                     
                                                                                           
  Ischemic heart disease (yes)                   0.555                                     
                                                                                           
  Presence of lifestyle disease (yes)            0.340                                     
                                                                                           
  Smoking                                        0.021                                     0.055
                                                                                           
  Forced expiratory volume in the first second   0.380                                     
                                                                                           
  Body mass index                                0.024                                     0.244
                                                                                           
  Surgical technique                             0.679                                     
                                                                                           
  Operation time                                 0.494                                     
                                                                                           
  Tumor location                                 0.962                                     
                                                                                           
  Tumor laterality                               0.591                                     
                                                                                           
  Resection type                                 0.001                                     
                                                                                           
   Lobectomy                                                        Reference              
                                                                                           
   Bilobectomy/pneumonectomy                                        2.201 (1.079--4.490)   0.030
                                                                                           
  Pathologic stage                               0.016                                     
                                                                                           
   IA                                                               Reference              
                                                                                           
   IB                                                               1.888 (1.021--3.491)   0.043
                                                                                           
  Histologic type                                0.703                                     
                                                                                           
  Postoperative complication (yes)               0.576                                     
